Proteotype Diagnostics Ltd.

Developing low-cost diagnostic tool to detect earl-stage cancer, Auto-immune, and neuro-degenerative diseases using novel blood borne analytes

Proteotype Diagnostics Ltd. was founded in 2019 by Emma Yates, PHD, Wesley Sukdao and Gonçalo Bernardes, PhD in Cambridge, United Kingdon to develop a novel liquid biopsy diagnostic for multiple classes of disease. By measuring naturally occurring analytes in their native solution, the company can quantify cross-sectional snapshots that together compose a signature for healthy and disease states as wel as predicting repsonse to various forms of treatment. Prototype has achieved clinical proof of concept and the mechanism of actioin underlying there platform.